Advertisement
Advertisement
SRTA
Strata Critical Medical, Inc. Class A Common Stock
4.83
USDSponsored
+0.07
+1.37%
Oct 29, 10:36 UTC -4
Open
Strata Critical Medical, Inc. Class A Common Stock (SRTA) Earnings
SRTA Earnings Reports
Positive Surprise Ratio
SRTA beat 9 of 18 last estimates.
50%
Next Report
Date of Next Report
Nov 09, 2026
Estimate for Q3 26 (Revenue/ EPS)
$74.12M
/$0.00
Implied change from Q2 26 (Revenue/ EPS)
+2.23%
/-100.00%
Implied change from Q3 25 (Revenue/ EPS)
+50.36%
/-100.00%
Strata Critical Medical, Inc. Class A Common Stock earnings per share and revenue
On Aug 04, 2026, SRTA reported earnings of -0.12 USD per share (EPS) for Q2 26, missing the estimate of 0.00 USD, resulting in a -1618.99% surprise. Revenue reached 72.51 million, compared to an expected 68.45 million, with a 5.92% difference. The market reacted with a +0.36% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of 0.00 USD, with revenue projected to reach 74.12 million USD, implying an decrease of -100.00% EPS, and increase of 2.23% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Teladoc Health, Inc.
Report Date
Oct 28, 2026 For Q3 26
Estimate
-$0.21
Actual
-$0.15
Surprise
+29.35%
Danaher Corporation
Report Date
Oct 21, 2026 For Q3 26
Estimate
$1.93
Actual
$2.11
Surprise
+8.99%
HCA Healthcare, Inc.
Report Date
Oct 27, 2026 For Q3 26
Estimate
$6.72
Actual
$7.22
Surprise
+7.29%
Elevance Health, Inc.
Report Date
Oct 21, 2026 For Q3 26
Estimate
$4.72
Actual
$6.99
Surprise
+47.81%
Labcorp Holdings Inc.
Report Date
Oct 28, 2026 For Q3 26
Estimate
$4.79
Actual
$4.78
Surprise
-0.31%
Medpace Holdings, Inc. Common Stock
Report Date
Oct 21, 2026 For Q3 26
Estimate
$4.52
Actual
$4.84
Surprise
+6.98%
Icon Plc
Report Date
Oct 27, 2026 For Q3 26
Estimate
$2.65
Actual
$2.66
Surprise
+0.27%
Avantor, Inc.
Report Date
Oct 28, 2026 For Q3 26
Estimate
$0.21
Actual
$0.22
Surprise
+3.92%
Bausch + Lomb Corporation
Report Date
Oct 28, 2026 For Q3 26
Estimate
$0.22
Actual
$0.34
Surprise
+53.43%
Pediatrix Medical Group, Inc.
Report Date
Oct 29, 2026 For Q3 26
Estimate
$0.66
Actual
$0.72
Surprise
+7.61%
FAQ
What were Strata Critical Medical, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Strata Critical Medical, Inc. Class A Common Stock reported EPS of -$0.12, missing estimates by -1618.99%, and revenue of $72.51M, 5.92% above expectations.
How did the market react to Strata Critical Medical, Inc. Class A Common Stock's Q2 2026 earnings?
The stock price moved up 0.36%, changed from $5.55 before the earnings release to $5.57 the day after.
When is Strata Critical Medical, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Nov 09, 2026.
What are the forecasts for Strata Critical Medical, Inc. Class A Common Stock's next earnings report?
Based on 3
analysts, Strata Critical Medical, Inc. Class A Common Stock is expected to report EPS of -- and revenue of $74.12M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.